Axefur

Axefur250 mg

Cefuroxime Axetil

Amulet Pharmaceuticals Ltd.

Product Code : 1681
MRP 25.00
10% Off
Best PriceTk
/
Out Of Stock
1
Section

Alternatives

See All
Product Image
10% Off

Cefotil250 mg

Cefuroxime Axetil

Square Pharmaceuticals Ltd.

22.65
25.17
Add to cart
Product Image
10% Off

Furocef250 mg

Cefuroxime Axetil

Renata Limited

22.58
25.09
Add to cart
Product Image
10% Off

Furotil250 mg

Cefuroxime Axetil

Healthcare Pharmacuticals Ltd.

22.50
25.00
Add to cart
Product Image
10% Off

Merocef250 mg

Cefuroxime Axetil

Ibn-Sina Pharmaceuticals Ltd.

23.40
26.00
Add to cart
Product Image
10% Off

Kilmax250 mg

Cefuroxime Axetil

Eskayef Bangladesh Ltd.

22.50
25.00
Add to cart
Product Image
10% Off

Furex250 mg

Cefuroxime Axetil

Drug International Ltd.

22.59
25.10
Add to cart
Product Image
10% Off

Cerox-A250 mg

Cefuroxime Axetil

ACI Limited

22.65
25.17
Add to cart
Product Image
10% Off

Cefuson250 mg

Cefuroxime Axetil

Jayson Pharma Ltd.

22.50
25.00
Add to cart
Product Image
10% Off

Famicef250 mg

Cefuroxime Axetil

ACME Laboratories Ltd.

22.65
25.17
Add to cart
Product Image
10% Off

Fixcef250 mg

Cefuroxime Axetil

Navana Pharmaceuticals Ltd.

22.57
25.08
Add to cart
Product Image
10% Off

Cefobac250 mg

Cefuroxime Axetil

Popular Pharmaceuticals Ltd.

22.58
25.09
Add to cart
Product Image
10% Off

Axim250 mg

Cefuroxime Axetil

Aristopharma Ltd.

22.50
25.00
Add to cart
Product Image
10% Off

Furoget250 mg

Cefuroxime Axetil

Get Well Ltd.

21.60
24.00
Add to cart
Product Image
10% Off

Axicef250 mg

Cefuroxime Axetil

Unimed Unihealth MFG. Ltd.

22.50
25.00
Add to cart
Product Image
10% Off

Fuxtil250 mg

Cefuroxime Axetil

Pharmasia Limited

22.50
25.00
Out Of Stock
Product Image
10% Off

Kilbac250 mg

Cefuroxime Axetil

Incepta Pharmaceuticals Ltd.

22.50
25.00
Add to cart
Product Image
10% Off

Axibid250 mg

Cefuroxime Axetil

Nuvista Pharma Ltd.

22.57
25.08
Add to cart
Product Image
10% Off

Axet250 mg

Cefuroxime Axetil

Orion Pharma Ltd.

22.64
25.16
Add to cart
Product Image
10% Off

Mextil250 mg

Cefuroxime Axetil

Biopharma Laboratories Ltd.

22.65
25.17
Add to cart
Product Image
8% Off

Refurox250 mg

Cefuroxime Axetil

Radiant Pharmaceuticals Ltd.

32.20
35.00
Add to cart
Product Image
8% Off

Rofurox250 mg

Cefuroxime Axetil

Radiant Pharmaceuticals Ltd.

36.80
40.00
Add to cart
Product Image
10% Off

Roxibac250 mg

Cefuroxime Axetil

Julphar Bangladesh Ltd.

22.50
25.00
Add to cart
Product Image
8% Off

Roxicil250 mg

Cefuroxime Axetil

Radiant Pharmaceuticals Ltd.

27.68
30.09
Add to cart
Product Image
10% Off

Roxilab250 mg

Cefuroxime Axetil

Labaid Pharma Ltd.

22.57
25.08
Add to cart
Product Image
10% Off

Secomax250 mg

Cefuroxime Axetil

General Pharmaceuticals Ltd.

22.64
25.16
Add to cart
Product Image
10% Off

Sefur250 mg

Cefuroxime Axetil

Opsonin Pharma Ltd.

22.64
25.16
Add to cart
Product Image
8% Off

Sefurox250 mg

Cefuroxime Axetil

Synovia Pharma PLC

23.16
25.17
Add to cart
Product Image
10% Off

Segorin250 mg

Cefuroxime Axetil

Pacific Pharmaceuticals Ltd.

22.50
25.00
Add to cart
Product Image
10% Off

Staxim250 mg

Cefuroxime Axetil

Delta Pharma Ltd.

22.50
25.00
Add to cart
Product Image
10% Off

Turbocef250 mg

Cefuroxime Axetil

Beximco Pharmaceuticals Ltd.

22.50
25.00
Add to cart
Product Image
10% Off

Winfax250 mg

Cefuroxime Axetil

The White Horse Pharma

22.50
25.00
Out Of Stock
Product Image
10% Off

Xefrim250 mg

Cefuroxime Axetil

Beacon Pharmaceuticals Ltd.

22.57
25.08
Add to cart
Product Image
10% Off

Ximetil250 mg

Cefuroxime Axetil

Globe Pharmaceuticals Ltd.

22.50
25.00
Add to cart
Product Image
10% Off

Xinarox250 mg

Cefuroxime Axetil

NIPRO JMI Pharma Ltd.

22.57
25.08
Add to cart
Product Image
10% Off

Xitil250 mg

Cefuroxime Axetil

Ziska Pharmaceuticals Ltd.

22.51
25.01
Add to cart
Product Image
7% Off

Xorimax250 mg

Cefuroxime Axetil

SANDOZ (A Novartis Division)

28.37
30.50
Add to cart
Section

Medicine overview

Indications of Axefur 250 mg

It is indicated for the treatment of infections caused by sensitive bacteria. Pharyngitis/Tonsillitis caused by Streptococcus pyogenes. Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes. ... Read moreIt is indicated for the treatment of infections caused by sensitive bacteria. Pharyngitis/Tonsillitis caused by Streptococcus pyogenes. Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes. Acute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non beta-lactamase producing strains) Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, E. coli Acute bacterial exacerbation of chronic bronchitis and Secondary bacterial infections of Acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (beta-lactamase negative strains) or Haemophilus parainfluenzae (beta-lactamase negative strains). Skin and skin-structure infections caused by Staphylococcus aureus (including beta-lactamase producing strains) or Streptococcus pyogenes. Urinary tract infections caused by E.coli or Klebsiella pneumoniae. Bone and Joint Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains). Gonorrhoea caused by penicillinase-producing and non-penicillinase producing strains of Neisseria gonorrhoeae. Early Lyme Disease (erythema migrans) caused by Borrelia burgdorferi.

Theropeutic Class

Second generation Cephalosporins

Pharmacology

Cefuroxime is a well-characterized and effective antibacterial agent, which has broad-spectrum bactericidal activity against a wide range of common pathogens, including β-lactamase producing strains. Cefuroxime has good stability to bacterial β-lactamase and consequently, is active against many ampicillin-resistant and amoxycillin-resistant strains.

Dosage of Axefur 250 mg

Tablet or Suspension- Adolescents and adults (13 years and older)- Pharyngitis/tonsillitis: 250 mg b.i.d. for 5-10 days Acute bacterial maxillary sinusitis: 250 mg b.i.d. for 10 days Acute bacterial exacerbation of chronic bronchitis: 250-500 mg b.i.d. for 10 days Secondary bacterial infections of acute bronchitis: 250-500 mg b.i.d. for 5-10 days Uncomplicated skin and skin structure infections: 250-500 mg b.i.d. for 10 days Uncomplicated urinary tract infections: 250 mg b.i.d. for 7-10 days Uncomplicated Gonorrhoea: 1000 mg Single dose Community acquired pneumonia: 250-500 mg b.i.d. for 5-10 days MDR Typhoid Fever: 500 mg b.i.d. for 10-14 days Early Lyme disease: 500 mg b.i.d. for 20 days Paediatric Patients (3 months to 12 years)- Pharyngitis/Tonsillitis: 20 mg/kg/day b.i.d for 5-10 days Acute otitis media: 30 mg/kg/day b.i.d for 10 days Acute bacterial maxillary sinusitis: 30 mg/kg/day b.i.d for 10 days Impetigo: 30 mg/kg/day b.i.d for 10 days Parenteral- Adult: 750 mg three times daily by IM or IV injection. In severe infections, dose can be increased upto 1.5 gm three times daily by IV injection. The frequency may be increased to four times daily, if necessary, giving total daily doses of 3 to 6 gms. Children (above 3 months of age): 30 - 100 mg/kg/day given in 3 or 4 equally divided doses. A dose of 60 mg/kg/day is appropriate for most infections. Neonate: 30 - 100 mg/kg/day given in 2 or 3 equally divided doses. Surgical prophylaxis: 1.5 gm by IV injection at induction of anaesthesia; up to 3 further doses of 750 mg may be given by IV/IM injection every 8 hours for high risk procedures. Pneumonia: 1.5 gm IV injection twice daily for 2-3 days, followed by 500 mg twice daily (oral) for 7-10 days. Acute exacerbations of chronic bronchitis: 750 mg twice daily (IM or IV injection) for 2-3 days, followed by 500 mg twice daily (oral) for 5-10 days. (Duration of both parenteral and oral therapy is determined by the severity of the infection and the clinical status of the patient.) In Gonorrhoea: Adult: 1.5 gm as a single dose (as 2 x 750mg injections intramuscularly with different sites, e.g. each buttock). In Meningitis: Adult: 3 gm IV injection three times daily. Children (above 3 months of age): 200-240 mg/kg/day by IV injection in 3 or 4 divided doses reduced to 100 mg/kg/day after 3 days or on clinical improvement. Neonate: 100 mg/kg/day by IV injection at initial dose, reduced to 50 mg/kg/day, When clinically indicated. In bone and joint infections: Adult: 1.5 gm IV injection four times daily. Children (above 3 months of age): 150 mg/kg/day (not to exceed the maximum adult dose) in equally divided doses every 8 hours.

Administration of Axefur 250 mg

The use of freshly reconstituted solution is recommended. However, it maintains potency for at least 24 hours at room temperature or 48 hours at 5o C

Interaction of Axefur 250 mg

No potentially hazardous interactions have been reported.

Contraindications

Cefuroxime is contraindicated in patients with known allergy to Cephalosporins.

Side Effects of Axefur 250 mg

Adverse effects to Cefuroxime have occurred infrequently and have been generally mild and transient in nature. Effects reported include rashes and gastrointestinal disturbances. As with other antibiotics, prolonged use may result in the overgrowth of non susceptible organisms e.g. Candida.

Pregnancy & Lactation

US FDA pregnancy category of Cefuroxime is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cefuroxime have been shown to be excreted in human milk. So, caution should be exercised when Cefuroxime is administered to a nursing woman.

Precautions & Warnings

Cefuroxime should be given with care to patients receiving concurrent treatment with potent diuretics & who has history of colitis. Cephalosporin antibiotics may in general be given safely to patients who are hypersensitive to penicillin although cross reactions have reported. Cefuroxime has shown, that is not likely to be a problem at the recommended to dose levels.

Storage Conditions

Store in a cool, dry place (below 30o C), away from light & moisture. Keep out of the reach of children.

Reconstitution

For 750 mg intramuscular injection: Add 3 ml water for injection to vial and then shake gently for dispersion.For 750 mg intravenous injection: Add 8 ml water for injection to vial and then shake gently for dispersion. The solution should be slowly injected directly into a vein over a 3 to 5 minutes period.For 1.5 g intravenous injection: Add 16 ml Water for injection to vial and then shake gently for dispersion. The solution should be slowly injected directly into a vein over a 3 to 5 minutes period.

Drug Classes

Second generation Cephalosporins

Mode Of Action

Cefuroxime is a well-characterized and effective antibacterial agent, which has broad-spectrum bactericidal activity against a wide range of common pathogens, including β-lactamase producing strains. Cefuroxime has good stability to bacterial β-lactamase and consequently, is active against many ampicillin-resistant and amoxycillin-resistant strains.

Pregnancy

US FDA pregnancy category of Cefuroxime is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cefuroxime have been shown to be excreted in human milk. So, caution should be exercised when Cefuroxime is administered to a nursing woman.
Disclaimer

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.